BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 29/02/2012

FDA Clears Path for Abbreviated Approval of Phenacemide Tablet

The FDA has ruled that the 500mg phenacemide tablet was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of generic versions of the medication.

Source: Federal Register — Food and Drug AdministrationOpen original release →